AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

BIOME TECHNOLOGIES PLC

Earnings Release Apr 20, 2022

7519_rns_2022-04-20_42020a8e-937e-4685-a4fd-2f9ccf495093.html

Earnings Release

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 6551I

Biome Technologies PLC

20 April 2022

The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310.

20 April 2022

Biome Technologies plc

("Biome", "the Company" or "the Group")

Trading Update

Biome Technologies plc, a leading bioplastics and radio frequency technology business, today provides an unaudited Trading Update for the quarter ended 31 March 2022.

Group revenues for the quarter ended 31 March 2022 were in line with management expectations at £1.1m (Q1 2021: £1.4m).

Bioplastics Division

The division's revenues for Q1 were £1.0m (Q1 2021: £1.2m). Further substantial revenue growth from this division is anticipated during 2022 as some of the previously reported logistics issues clear and a number of important customer positions accelerate or move into a commercial phase.

Stanelco RF Technologies Division

Revenues in the RF Technologies division in Q1 were £0.1m (Q1 2021: £0.2m). The division has a strong orderbook, announced previously, that are currently in production and are expected to deliver revenue both in Q2 and into the second half of the year.  A solid pipeline of opportunities from our target markets are under discussion and continued good order intake is encouraging.

Group Performance

The Group had a cash balance as at 31 March 2022 of £0.9m (31 March 2021: £1.6m). As at 19 April 2022, the Group had cash of £0.9m and no debt.

Group Outlook

The Board's view of the Group's performance remains in line with current market expectations.

-Ends-

For further information please contact: Biome Technologies plc
Paul Mines, Chief Executive Officer
Rob Smith, Chief Financial Officer
www.biometechnologiesplc.com Tel: +44 (0) 2380 867 100
Allenby Capital
David Hart/Alex Brearley (Nominated Adviser)

Kelly Gardiner (Sales and Corporate Broking)
www.allenbycapital.com Tel: +44 (0) 20 3328 5656

About Biome

Biome Technologies plc is an AIM listed, growth-orientated, commercially driven technology group. Our strategy is founded on building market-leading positions based on patented technology and serving international customers in valuable market sectors. We have chosen to do this by developing products in application areas where the value-added pricing can be justified and are not reliant on government legislation. These products are driven by customer requirements and are compatible with existing manufacturing processes. They are market rather than technology-led.

The Group comprises two divisions, Biome Bioplastics Limited ("Bioplastic") and Stanelco RF Technologies Limited ("RF Technologies").

Biome Bioplastics is a leading developer of highly-functional, bio-based and biodegradable plastics. The company's mission is to produce bioplastics that challenge the dominance of oil- based polymers.

Stanelco RF Technologies designs, builds and services advanced radio frequency (RF) systems. Dielectric and induction heating products are at the core of a product offering that ranges from portable sealing devices to large furnaces for the fibre optics markets.

www.biometechnologiesplc.com www.biomebioplastics.com and www.thinkbioplastic.com www.stanelcorftechnologies.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TSTBKCBBABKDDQD

Talk to a Data Expert

Have a question? We'll get back to you promptly.